SCHEMBL6778305

SCHEMBL6778305

CCOc1ccccc1C(=O)N(Cc1ccccc1-c1ccccc1)c1ccc(OC)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTB4R2 Q9NPC1 2/20 0.52
▸ MAPT P10636 2/20 0.49
▸ ALDH1A1 P00352 4/20 0.47
▸ LMNA P02545 3/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ HPGD P15428 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TP53 P04637 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ ATM Q13315 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ FFAR1 O14842 1/20 0.41
▸ FFAR4 Q5NUL3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6780398 0.91 LMNA (0.51) LTB4R2ALDH1A1LMNATP53FFAR1
SCHEMBL6778429 0.86 MAPT (0.50) LTB4R2MAPTALDH1A1LMNAL3MBTL1
SCHEMBL6780224 0.86 OXTR (0.51) MAPTALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL6781046 0.85 MEN1 (0.49) LTB4R2ALDH1A1LMNAL3MBTL1HPGD
SCHEMBL6779695 0.84 LMNA (0.49) LTB4R2ALDH1A1LMNAHPGDMEN1
SCHEMBL6778364 0.82 PTGES (0.56) LTB4R2MAPTALDH1A1LMNAHPGD
SCHEMBL6784549 0.82 LTB4R2 (0.48) LTB4R2ALDH1A1LMNAHPGDMEN1
SCHEMBL6781088 0.82 ALDH1A1 (0.45) LTB4R2MAPTALDH1A1L3MBTL1HTT
SCHEMBL6783823 0.80 ALDH1A1 (0.47) MAPTALDH1A1LMNAL3MBTL1MEN1
SCHEMBL6775891 0.80 PDK1 (0.47) LTB4R2MAPTALDH1A1L3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT LTB4R2 1613/4885MAPT 3054/4885ALDH1A1 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback